use
plantbas
materi
date
back
earli
period
human
exist
sever
ancient
record
provid
formul
evid
phytotherapi
knowledg
deriv
ancient
tradit
system
medicin
transcend
modern
pharmaceut
industri
focu
phytochem
research
often
discov
new
drug
drug
lead
medicin
plant
one
import
issu
medicin
plant
research
appropri
select
target
plant
speci
may
provid
lead
new
drug
throughout
histori
drug
discoveri
plant
serendip
play
signific
role
kinghorn
kubinyi
exampl
discoveri
dicoumarol
fatal
cattl
poison
melilotu
officinali
simpli
serendipit
discoveri
kubinyi
led
develop
wellknown
anticoagul
warfarin
fig
conduct
research
without
work
hypothes
may
produc
unexpect
discoveri
chanc
success
much
slimmer
target
approach
research
medicin
plant
thu
requir
thorough
knowledg
variou
properti
may
reflect
hitherto
unknown
medicin
properti
plant
challeng
lie
devis
appropri
method
uncov
exist
potenti
medicin
properti
well
select
right
plant
may
fulfil
criteria
plant
said
medicin
possess
certain
medicin
cur
properti
ailment
group
ailment
efficaci
herbal
medicin
phytotherapi
treatment
sever
diseas
may
sometim
link
placebo
effect
often
involv
activ
natur
product
mostli
low
molecular
weight
possess
druglik
properti
earliest
known
investig
bioactiv
plant
date
back
bce
egyptian
scroll
detail
plant
along
medicin
properti
modern
studi
bioactiv
compound
isol
live
organ
therapeut
purpos
began
around
year
ago
isol
morphin
fw
serturn
schmitz
turn
back
acceler
process
phytochem
discoveri
tremend
advanc
phytochem
method
medicin
chemistri
alli
disciplin
plantbas
medicin
contribut
continu
advanc
modern
medic
treatment
provis
new
drug
candid
howev
sometim
progress
medicin
plant
research
somehow
neg
impact
introduct
variou
modern
technologybas
develop
synthet
medicin
chemistri
eg
combinatori
chemistri
sheer
complet
librarybas
highthroughputscreen
ht
process
modern
drug
discoveri
scene
howev
inher
chemic
divers
structur
novelti
natur
product
offer
best
reason
natur
product
drug
discoveri
plant
remain
one
main
sourc
new
drug
one
bottleneck
phytochem
drug
discoveri
probabl
arduou
protocol
addit
overal
cost
convent
plant
drug
discoveri
methodolog
sometim
prohibit
drug
discoveri
initi
come
costeffect
mitig
issu
variou
stage
plantbas
drug
discoveri
programm
requir
much
smarter
approach
incorpor
new
comput
approach
coupl
mathemat
model
thousand
structur
divers
bioactiv
compound
evolv
plant
develop
evolutionari
process
sometim
offer
plant
necessari
protect
herbivor
pathogen
other
serv
signal
compound
facilit
reproduct
antioxid
uv
protect
isol
analysi
potenti
bioactiv
phytochem
may
includ
gener
hypothesi
target
receptor
particular
disord
subsequ
screen
vitro
andor
vivo
biolog
activ
candid
drug
major
challeng
phytochemistri
describ
understand
divers
molecul
mode
action
determin
natur
combin
found
plant
sarker
nahar
wink
howev
right
begin
plantbas
drug
discoveri
programm
probabl
import
task
appropri
select
medicin
plant
vast
array
plant
avail
earth
may
possess
expect
desir
bioactiv
success
drug
discoveri
programm
often
depend
accur
data
pharmacokinet
metabol
initi
absorpt
distribut
metabol
excret
toxic
screen
contribut
success
rate
compound
clinic
trial
pharmacokinet
paramet
provid
inform
futur
experi
involv
anim
model
clinic
studi
select
dose
level
frequenc
administr
apart
variou
techniqu
approach
attempt
predict
potenti
medicin
activ
plant
one
attempt
applic
phylogenet
method
chemotaxonom
understand
determin
pattern
evolut
variou
group
special
metabolit
deriv
correl
phylogeni
biosynthet
pathway
et
al
also
attempt
correl
tast
medicin
plant
ethnopharmacolog
activ
gilca
barbulescu
novel
improvis
method
increasingli
use
variou
mathemat
model
comput
approach
regress
analysi
data
mine
analys
structureact
relationship
see
chapter
fundament
aim
chapter
present
overview
method
process
involv
plant
select
util
variou
mathemat
model
comput
techniqu
mathemat
model
defin
descript
system
use
mathemat
concept
languag
facilit
proper
explan
system
studi
effect
differ
compon
make
predict
pattern
behaviour
abramowitz
stegun
process
construct
mathemat
model
often
call
mathemat
model
press
et
al
mathemat
model
known
variou
name
predict
model
simul
decis
analysi
tradit
mathemat
model
compris
four
major
element
govern
equat
defin
equat
constitut
equat
constraint
mathemat
model
depend
advanc
comput
tool
simul
medic
outcom
given
paramet
common
methodolog
markov
chain
mont
carlo
simul
mathemat
model
appli
predict
outcom
particularli
help
limit
like
rare
event
prohibit
repeat
actual
studi
expand
research
clinic
trial
innov
use
techniqu
includ
estim
miss
data
point
common
strategi
replac
miss
valu
includ
point
central
tendenc
eg
mean
median
method
usual
cut
criterion
minimum
allow
proport
technic
limit
preserv
varianc
markov
chain
first
use
model
nuclear
reaction
mckean
seri
condit
probabl
fix
depend
order
techniqu
gener
limit
applic
differ
disciplin
one
could
deriv
singl
probabl
function
markov
process
name
russian
mathematician
andrey
markov
stochast
process
satisfi
markov
properti
simpli
process
satisfi
markov
properti
one
predict
futur
process
base
sole
present
state
well
one
could
know
process
full
histori
markov
chain
type
markov
process
either
discret
state
space
discret
index
set
often
repres
time
precis
definit
markov
chain
may
vari
mont
carlo
simul
seri
random
draw
simul
event
within
known
paramet
probabl
distribut
event
computer
mathemat
techniqu
algorithm
allow
peopl
account
risk
quantit
analysi
decisionmak
mont
carlo
simul
offer
decisionmak
rang
possibl
outcom
probabl
occur
choic
action
simul
techniqu
came
use
applic
time
markov
chain
process
principl
mont
carlo
method
use
solv
problem
probabilist
interpret
law
larg
number
integr
describ
expect
valu
random
variabl
approxim
take
empir
mean
independ
sampl
variabl
probabl
distribut
variabl
parameter
mathematician
often
use
markov
chain
mont
carlo
mcmc
sampler
del
moral
et
al
kroes
et
al
mcmc
estim
valu
preserv
actual
varianc
mont
carlo
simul
sever
advantag
determinist
singlepoint
estim
analysi
advantag
enhanc
mont
carlo
simul
use
latin
hypercub
sampl
lh
sampl
accur
entir
rang
distribut
function
lh
first
introduc
mckay
statist
method
gener
nearrandom
sampl
paramet
valu
multidimension
distribut
mckay
et
al
tang
sampl
method
often
use
construct
computer
experi
montecarlo
integr
mani
mathemat
model
approach
includ
simul
data
appli
determin
medicin
properti
plant
exampl
applic
mathemat
model
predict
medicin
properti
plant
select
discuss
section
comput
model
mathemat
model
comput
scienc
requir
extens
comput
resourc
studi
behaviour
complex
system
comput
simul
thu
comput
model
refer
use
comput
simul
studi
behaviour
complex
system
use
mathemat
physic
comput
scienc
comput
model
may
contain
numer
variabl
character
system
investig
computeraid
drug
discoveri
cadd
method
contribut
significantli
develop
therapeut
import
small
molecul
either
synthet
natur
sourc
song
et
al
cadd
method
significantli
decreas
number
compound
necessari
screen
retain
level
lead
compound
discoveri
mani
compound
predict
inact
easili
skip
predict
activ
priorit
thu
reduc
cost
workload
full
ht
screen
without
compromis
lead
discoveri
cadd
method
increas
hit
rate
novel
drug
compound
use
much
target
search
tradit
ht
combinatori
chemistri
aim
explain
molecular
basi
therapeut
activ
also
help
predict
possibl
deriv
improv
activ
mainli
method
classifi
structurebas
ligandbas
method
sliwoski
et
al
structurebas
method
reli
knowledg
target
protein
structur
estim
interact
energi
compound
test
hand
ligandbas
cadd
util
knowledg
known
activ
inact
molecul
chemic
similar
search
construct
quantit
structureact
relationship
qsar
model
import
tool
eg
target
ligand
databas
homolog
model
ligandfingerprint
method
necessari
success
implement
variou
computeraid
drug
discoverydesign
method
modern
drug
discoveri
programm
comput
method
toxic
predict
optim
favour
physiolog
properti
also
part
modern
drug
discoveri
design
protocol
variou
approach
computeraid
drug
design
repres
follow
figur
fig
aparoy
et
al
mani
mathemat
model
approach
includ
simul
data
use
determin
medicin
properti
plant
comput
method
power
knowledgebas
approach
help
select
plant
materi
natur
product
high
likelihood
biolog
activ
method
also
offer
ration
biolog
activ
natur
product
silico
simul
use
propos
protein
ligandbind
characterist
principl
structurebas
cadd
similar
ht
target
ligand
structur
inform
essenti
douguet
et
al
structurebas
approach
includ
ligand
dock
pharmacophor
ligand
design
method
structurebas
cadd
reli
knowledg
target
protein
structur
calcul
interact
energi
compound
test
sliwoski
et
al
structurebas
drug
discoveri
approach
therapeut
design
base
knowledg
target
structur
leelananda
lindert
approach
depend
abil
determin
analyz
threedimension
structur
biolog
molecul
base
hypothesi
molecul
abil
interact
specif
protein
exert
desir
biolog
effect
depend
abil
favour
interact
particular
bind
site
protein
sliwoski
et
al
molecul
share
favour
interact
possess
similar
biolog
effect
therefor
novel
compound
determin
analysi
protein
bind
site
prerequisit
approach
structur
inform
access
target
databas
one
import
requir
abil
rapidli
determin
potenti
binder
target
biolog
interest
comput
model
appli
rapid
screen
larg
compound
librari
determin
potenti
binder
model
simul
visual
techniqu
ideal
start
point
dock
determin
target
structur
experiment
confirm
xray
crystallographi
nmr
techniqu
evalu
appropri
bind
pocket
usual
perform
analysi
known
targetligand
cocryst
structur
altern
method
use
silico
method
identifi
novel
bind
site
experiment
structur
avail
absent
comput
model
util
predict
structur
target
protein
target
structur
may
predict
base
templat
similar
sequenc
process
call
compar
model
base
belief
protein
structur
better
conserv
sequenc
protein
similar
sequenc
similar
structur
essenc
compar
model
involv
follow
step
identif
relat
protein
serv
templat
structur
sequenc
align
target
templat
protein
copi
coordin
confid
align
region
construct
miss
atom
coordin
target
structur
model
refin
evalu
process
autom
comput
programm
eg
psipr
model
etc
one
signific
approach
homolog
model
templat
target
protein
share
evolutionari
origin
homolog
model
popular
comput
method
predict
coordin
structur
homolog
model
also
known
compar
model
protein
actual
refer
construct
atomicresolut
model
target
protein
amino
acid
sequenc
experiment
structur
relat
homolog
protein
commonli
refer
templat
basi
approach
fact
evolutionrel
protein
often
share
similar
structur
protein
structur
gener
remain
conserv
sequenc
evolut
understand
structur
amino
acid
sequenc
similar
target
sequenc
interest
may
assist
predict
target
structur
function
possibl
bind
function
site
leelananda
lindert
applic
homolog
model
emerg
main
altern
get
represent
target
absenc
crystal
structur
aparoy
et
al
combin
homolog
model
dock
studi
contribut
identif
oxidosqualen
cyclas
associ
primari
secondari
metabol
centella
asiatica
kumar
et
al
understand
structur
function
chalcon
synthas
protein
coleu
forskohlii
comput
tool
becom
essenti
bind
site
detect
character
fundament
identif
activ
drug
bioactiv
molecul
bind
site
detect
cocryst
structur
target
close
relat
protein
absenc
cocryst
structur
mutat
studi
use
identifi
ligandbind
site
comput
method
use
absenc
bind
site
need
identif
new
bind
site
comput
method
divid
three
gener
group
geometr
algorithm
find
shape
concav
invagin
target
method
base
energet
consider
method
consid
dynam
protein
structur
optim
interact
ligand
target
identifi
steric
electron
featur
deriv
pharmacophor
model
model
usual
defin
hydrogen
bond
acceptor
hydrogen
bond
donor
basic
group
acid
group
partial
charg
aliphat
hydrophob
moieti
aromat
hydrophob
moieti
pharmacophor
model
use
queri
databas
bioactiv
compound
well
guid
design
new
compound
analysi
target
bind
site
studi
targetligand
complex
structur
use
perform
structurebas
pharmacophor
method
screen
natur
product
inhibitor
acetylcholinesteras
cyclooxygenas
use
proteinbas
pharmacophor
led
identif
scopoletin
potent
ach
acetylcholinesteras
inhibitor
sanggenon
potenti
cox
inhibitor
fig
barlow
et
al
molecular
dock
studi
establish
sieboldigenin
could
bind
activ
site
soybean
lipoxygenas
reduc
carrageenaninduc
paw
oedema
sterol
found
sever
speci
smilax
tradit
use
arthrit
skin
ailment
barlow
et
al
recent
year
screen
bioactiv
compound
base
target
recognit
becom
quit
popular
among
research
howev
method
hardli
effect
direct
screen
bioactiv
compound
plant
extract
often
complex
mixtur
mani
compound
gener
procedur
follow
strategi
isolationstructur
identificationact
confirm
one
novel
protocol
allow
determin
structur
inform
bioactiv
compound
without
isol
ligand
molecul
experiment
use
nmr
spectroscopi
techniqu
tang
et
al
ligandbas
method
use
ligand
inform
predict
activ
depend
similaritydissimilar
previous
known
activ
ligand
ligandbas
method
includ
ligandbas
pharmacophor
molecular
descriptor
quantit
structureact
relationship
ligandbas
cadd
exploit
knowledg
known
activ
inact
molecul
chemic
similar
search
construct
predict
quantit
structureact
relat
qsar
model
acharya
et
al
sliwoski
et
al
ligand
librari
usual
construct
enrich
ligand
desir
physiochem
properti
suitabl
target
interest
though
variou
dock
algorithm
avail
dock
million
compound
requir
consider
resourc
time
save
elimin
nondrug
like
unstabl
unfavour
compound
one
import
paramet
select
studi
drug
like
commonli
evalu
use
lipinski
rule
five
pfizer
rule
five
lipinski
et
al
rule
gener
state
oral
activ
drug
one
violat
follow
criteria
base
multipl
five
maximum
five
hydrogen
bond
donor
maximum
hydrogen
bond
acceptor
oxygen
nitrogen
atom
molecular
mass
less
da
octanolwat
partit
coeffici
greater
five
two
condit
violat
adsorpt
compromis
improv
predict
drug
like
rule
seen
mani
extens
polar
surfac
area
greater
molecular
weight
rang
molar
refract
partit
coeffici
rang
etc
initi
virtual
ht
molecul
filter
base
predict
admet
properti
predict
depend
statist
machinelearn
approach
molecular
descriptor
experiment
data
model
biolog
process
oral
bioavail
intestin
absorpt
permeabl
halflif
time
distribut
human
blood
plasma
sliwoski
et
al
drug
discoveri
process
lipophil
molecular
weight
often
increas
improv
affin
select
drug
candid
result
often
difficult
maintain
strict
drug
like
per
hit
lead
optim
propos
member
librari
bias
toward
lower
molecular
weight
lipophil
rule
five
extend
rule
three
defin
leadlik
compound
per
follow
criteria
congrev
et
al
octanolwat
partit
coeffici
log
p
greater
molecular
mass
less
da
three
hydrogen
bond
donor
three
hydrogen
bond
acceptor
three
rotabl
bond
lipinski
fifth
rule
state
origin
four
rule
appli
natur
product
molecul
recogn
activ
transport
system
consid
druggabl
chemic
entiti
newman
cragg
compound
librari
wessjohann
geysen
et
al
usual
enrich
particular
target
group
target
see
chapter
physiochem
filter
determin
observ
ligandtarget
complex
use
enrich
librari
search
ligand
similar
known
activ
ligand
molecul
flexibl
solvent
environ
represent
conform
flexibl
remain
import
criteria
determin
potenti
conform
protein
ligand
usual
precomput
use
comput
simul
knowledgebas
method
folopp
chen
ligandbas
computeraid
drug
design
involv
analysi
ligand
interact
target
molecul
method
requir
collect
refer
structur
collect
compound
interact
target
interest
object
activ
repres
compound
physicochem
properti
determin
desir
interact
two
main
approach
ligandbas
drug
design
method
select
compound
base
chemic
similar
known
activ
use
similar
measur
b
construct
qsar
model
analys
molecular
properti
convert
numer
vector
descriptor
convers
requir
ensur
descript
molecul
constant
length
independ
size
represent
inform
encod
molecular
structur
one
number
call
molecular
descriptor
characterist
use
establish
quantit
relationship
structur
properti
biolog
activ
experiment
properti
date
molecular
descriptor
encod
molecular
featur
report
molecular
descriptor
classifi
accord
dimension
ie
represent
molecul
descriptor
valu
comput
onedimension
descriptor
captur
bulk
properti
ie
molecular
weight
molar
refract
log
p
logarithm
octanolwat
partit
coeffici
etc
twodimension
descriptor
describ
properti
comput
twodimension
represent
molecul
number
atom
number
bond
connect
indic
etc
threedimension
descriptor
depend
conform
molecul
ie
solvent
access
surfac
area
princip
moment
inertia
van
der
waal
volum
etc
descriptor
deriv
structur
may
requir
analysi
mani
molecular
conform
biolog
activ
conform
usual
known
previou
experi
common
descriptor
may
includ
pharmacophor
type
represent
molecul
featur
known
thought
respons
biolog
activ
map
posit
molecul
molecular
descriptor
may
divid
accord
natur
constitut
fragment
addit
reflect
mostli
gener
properti
compound
topolog
calcul
use
mathemat
graph
theori
appli
scheme
atom
connect
structur
geometr
electron
quantumchem
last
three
deriv
result
empir
scheme
molecular
orbit
calcul
among
variou
approach
ligandbas
cadd
applic
quantit
structureact
relationship
qsar
contribut
significantli
develop
predict
model
qsar
method
base
assumpt
quantit
understand
role
molecular
structur
govern
biolog
attribut
method
tri
enumer
fragment
substructur
could
result
certain
activ
mani
case
sar
structureact
relationship
involv
enumer
fragment
substructur
biolog
activ
qsar
quantifi
descriptor
collect
refer
q
sar
puzyn
et
al
success
creation
qsar
model
demand
fulfil
follow
condit
consensu
data
structur
biolog
activ
studi
compound
extract
descriptor
present
structur
machinelearn
method
either
multipl
linear
regress
neural
network
random
forest
similar
support
vector
machin
etc
qsar
model
develop
homogen
data
known
local
model
tradit
use
optim
hit
lead
compound
hand
qsar
model
develop
base
heterogen
data
consid
global
model
wide
applic
domain
global
model
may
use
virtual
screen
predict
biolog
activ
target
fish
qsar
larg
potenti
across
industri
academia
regulatori
agenc
potenti
use
includ
identif
new
lead
pharmacolog
biocid
pesticid
activ
predict
toxic
ration
design
desir
product
select
compound
optim
pharmacokinet
properti
etc
research
tend
determin
potenti
target
new
chemic
entiti
follow
tool
use
studi
biolog
activ
pair
similar
known
compound
eg
tanimoto
coeffici
b
dock
eg
invdock
c
pharmacophorebas
virtual
screen
classif
predict
base
bayesian
statist
substructur
descriptor
fingerprint
success
predict
properti
chemic
entiti
includ
phytochem
depend
data
base
techniqu
develop
model
overal
qualiti
inform
includ
item
model
gener
two
type
inform
requir
model
effect
model
descriptor
chemic
techniqu
formul
relationship
data
model
qsar
may
denot
xmatrix
descriptor
ymatrix
tabl
use
matrix
variou
type
relationship
may
establish
statist
machinelearn
techniqu
qsar
base
continu
endpoint
activ
x
function
one
descriptor
develop
sar
associ
identif
firm
basi
relationship
compound
identifi
elicit
particular
effect
structur
determin
recogn
structur
fragment
determin
may
flag
structur
code
softwar
greater
number
compound
structur
determin
demonstr
effect
greater
confid
flag
associ
particular
effect
develop
sar
model
usual
appropri
qualit
yesno
activeinact
presenc
toxic
absenc
toxic
etc
endpoint
success
implement
qsar
depend
select
appropri
statist
machinelearn
algorithm
supplement
power
comput
tool
last
decad
multipl
linear
regress
mlr
one
popular
method
deriv
linear
map
howev
mlr
method
sever
limit
multicollinear
overfit
issu
nonlinear
relationship
therebi
make
research
look
altern
method
variou
method
neural
network
genet
algorithm
support
vector
machin
random
forest
appli
qsar
analysi
last
decad
sever
qsar
model
attempt
explain
describ
potenti
tradit
use
medicin
plant
howev
applic
qsar
method
herbal
formula
particularli
use
tradit
chines
medicin
ayurved
system
somewhat
limit
structur
composit
compound
formula
complet
known
thu
qsar
method
directli
applic
predict
bioactiv
polyherb
medicin
despit
variat
biolog
activ
herbal
medicin
also
associ
variat
chemic
composit
consid
relationship
anoth
relationship
call
quantit
composit
activ
relationship
qcar
propos
establish
relationship
chemic
composit
biolog
activ
method
appli
mathemat
model
use
qsar
studi
deriv
quantit
relationship
composit
bioactiv
herbal
compon
one
advantag
method
deriv
optim
combin
herbal
medicin
molecular
fingerprintbas
techniqu
one
approach
qualit
natur
compar
lbcadd
approach
sliwoski
et
al
molecular
fingerprint
represent
molecular
structur
properti
encod
binari
bit
string
whose
set
produc
bit
pattern
characterist
given
molecul
hert
et
al
fingerprint
may
provid
differ
set
molecular
descriptor
structur
fragment
possibl
connect
pathway
molecul
differ
type
pharmacophor
sever
methodolog
repres
chemic
binari
inform
instanc
pathbas
approach
keybas
fingerprint
dictionari
approach
smart
pattern
match
molecular
fingerprintbas
techniqu
use
repres
molecul
rapid
structur
comparison
phytochem
approach
depend
chemic
structur
less
comput
expens
pharmacophor
map
qsar
model
fingerprintbas
method
provid
equal
treatment
part
molecul
avoid
focu
part
molecul
consid
import
role
bioactiv
screen
phytochem
use
molecular
fingerprint
base
hiv
proteas
inhibitor
saquinavir
led
discoveri
potenti
antihiv
agent
leucovorin
molecular
dynam
studi
reveal
favour
bind
compound
proteas
activ
site
barlow
et
al
combin
molecular
fingerprintbas
method
dock
studi
led
discoveri
aurantiamid
acet
artemisia
annua
fig
inhibitor
sever
acut
respiratori
syndrom
coronaviru
main
proteinas
wang
et
al
ligandbasedcadd
machinelearn
algorithm
use
train
identifi
pattern
data
predict
test
data
set
one
common
algorithm
support
vector
machin
svm
usual
use
classif
set
biolog
data
leelananda
lindert
signific
candid
random
forest
svetnik
et
al
artifici
neural
network
wang
network
pharmacolog
new
paradigm
drug
discoveri
develop
hopkin
offer
enhanc
understand
drug
action
appli
network
analysi
determin
set
protein
critic
diseas
chemic
biolog
identifi
molecul
capabl
target
set
protein
address
true
complex
diseas
seek
har
abil
drug
influenc
mani
differ
protein
network
pharmacolog
differ
convent
drug
discoveri
approach
usual
base
highli
specif
target
singl
protein
network
pharmacolog
potenti
provid
new
treatment
complex
diseas
convent
approach
fail
deliv
satisfactori
therapi
advanc
bioinformat
system
biolog
polypharmacolog
networkbas
drug
discoveri
provid
promis
toward
costeffect
drug
discoveri
develop
tradit
herbal
medicin
network
analysi
studi
molecular
interact
relat
mathemat
field
graph
theori
assembl
pairwis
connect
edg
discret
object
node
coalesc
form
network
graph
arrel
terzic
biolog
network
deriv
de
novo
direct
experiment
interact
appli
known
interact
omic
dataset
revers
engin
gener
subset
network
ab
initio
predict
dynam
studi
past
concept
design
select
ligand
avoid
unwant
side
effect
major
issu
drug
discoveri
emerg
complex
drug
action
often
discov
may
mani
drug
drug
target
well
singl
drug
fit
multipl
drug
target
hopkin
network
pharmacolog
tri
understand
complex
relationship
along
valid
target
combin
optim
multipl
structureact
relationship
network
pharmacolog
system
biologybas
methodolog
tri
exploit
pharmacolog
mechan
drug
action
biolog
network
applic
network
analysi
herbal
medicin
network
mathemat
comput
represent
variou
connect
herbal
formula
diseas
complex
biolog
system
li
zhang
scope
new
approach
includ
studi
theori
algorithm
model
softwar
network
pharmacolog
network
construct
interact
predict
theori
method
dynam
optim
control
pharmacolog
network
network
analysi
pharmacolog
network
includ
flow
balanc
analysi
topolog
analysi
network
stabil
variou
pharmacolog
network
interact
factor
affect
drug
metabol
network
approach
search
target
discov
medicin
big
data
analyt
network
pharmacolog
zhang
one
import
contribut
network
pharmacolog
chang
perspect
one
target
one
drug
strategi
novel
version
network
target
multi
compon
strategi
perfectli
applic
tradit
chines
medicin
ayurved
medicin
system
one
pioneer
work
chines
research
li
propos
possibl
relationship
tradit
chines
medicin
syndrom
molecular
network
establish
networkbas
tcm
research
strategi
li
zhang
subsequ
also
propos
new
concept
network
target
approach
research
herbal
medicin
biolog
network
approach
node
repres
either
gene
gene
product
biolog
entiti
biomolecular
network
gene
regulatori
network
genet
interact
metabol
network
signal
network
b
herb
herb
ingredi
drug
c
clinic
phenotyp
diseas
network
edg
repres
associ
interact
welldefin
relationship
degre
node
repres
number
edg
connect
between
node
number
shortest
path
travers
given
node
network
paramet
between
degre
shortest
path
modul
use
measur
target
key
protein
protein
interact
potenti
network
pharmacolog
lie
multidisciplinari
approach
integr
larg
amount
inform
make
new
discoveri
combin
comput
experiment
approach
main
comput
approach
includ
graph
theori
statist
method
data
mine
model
inform
visual
method
network
pharmacolog
use
identifi
activ
herbal
ingredi
synergist
combin
well
contribut
ration
design
optim
drug
discoveri
process
herbal
formula
applic
network
map
wide
array
drug
protein
target
model
chemic
drugligand
interact
help
predict
new
target
also
enabl
identif
primari
site
action
offtarget
protein
explan
wellknown
side
effect
new
unexpect
drug
bind
reveal
across
major
categori
protein
unrel
sequenc
structur
arrel
terzic
document
analysi
legaci
knowledg
medicin
plant
provid
certain
advantag
identif
design
pharmacolog
product
plant
identif
select
medicin
plant
drug
discoveri
studi
challeng
task
medicin
plant
research
type
plant
select
would
right
criteria
still
remain
enigma
scientist
convent
target
approach
mann
et
al
favour
certain
medicin
plant
priorit
even
though
expens
depend
gener
work
hypothesi
perform
experiment
studi
base
hypothesi
approach
care
select
choos
right
criteria
target
botan
speci
usual
determin
outcom
consid
divers
higher
plant
select
candid
speci
bioprospect
programm
easi
task
total
number
higher
plant
estim
angiosperm
gymnosperm
screen
biolog
activ
phytochem
properti
rate
variou
research
institut
pharmaceut
industri
taken
differ
approach
categor
four
broad
groupsethnobotanydirect
random
select
chemotaxonom
integr
approach
respect
approach
ethnobotanydirect
chemotaxonom
integr
approach
part
target
approach
yea
et
al
tradit
medicin
use
mani
centuri
differ
cultur
medicin
plant
attract
lot
attent
sourc
medicin
product
approach
assum
tradit
use
plant
provid
strong
clue
biolog
activ
plant
cox
balick
drug
discoveri
procedur
plant
possess
potenti
medicin
properti
recogn
ethnobotan
field
studi
literatur
plant
investig
bioactiv
properti
laboratori
pure
compound
isol
prepar
procedur
tradit
recip
may
provid
indic
best
extract
protocol
formul
method
may
provid
primari
inform
pharmacolog
activ
optim
dose
suitabl
mode
applic
futur
drug
rate
ethnodirect
approach
initi
scientist
like
lui
lewin
carl
hartwich
alexand
tschirch
richard
evan
schult
appli
molecular
interpret
pharmacolog
activ
plant
earli
part
centuri
gertsch
earli
phase
ethnodirect
approach
anthropologist
work
tandem
chemist
pharmacologist
result
isol
variou
drug
molecul
caffein
quinin
fig
howev
spite
rich
ethnopharmacolog
survey
worldwid
divers
tradit
knowledg
mani
collect
data
could
translat
success
bioprospect
programm
albuquerqu
et
al
one
classic
exampl
shaman
pharmaceut
bioprospect
compani
establish
fail
deliv
blockbust
drug
spite
wealth
ethnopharmacolog
knowledg
subsequ
went
bankrupt
fact
signific
contribut
made
ethnodirect
approach
last
decad
gertsch
research
problem
like
inadequ
design
data
collect
misinterpret
role
medicin
play
tradit
medicin
system
unfavour
influenc
sampl
applic
irrelev
inform
consensu
indic
hamper
ethnobotanicaldirect
drug
discoveri
programm
individu
combin
albuquerqu
et
al
convent
ethnobotan
research
applic
comput
tool
along
statist
analysi
new
approach
still
rare
regress
analysi
medicin
plant
famili
uniqu
method
predict
plant
famili
larg
number
medicin
plant
method
first
introduc
moerman
classic
work
moerman
work
concern
predict
famili
larg
number
potenti
medicin
plant
base
linear
regress
analysi
work
mani
applic
approach
well
mani
deriv
includ
bayesian
approach
challeng
earlier
regress
method
bennett
husbi
moerman
howev
applic
regress
analysi
still
remain
popular
method
help
identif
plant
order
famili
favour
tradit
healer
among
ethnomedicin
plant
south
africa
prove
use
plant
tradit
healer
random
douw
et
al
attempt
appli
mathemat
logic
method
replac
rare
herb
simplifi
tradit
chines
medicin
formula
applic
perspect
pathway
enrich
analysi
fang
et
al
knowledg
particular
group
plant
contain
particular
group
natur
product
may
help
predict
presenc
similar
relat
compound
phylogenet
relat
speci
rate
chemotaxonomyguid
approach
chemic
plant
taxonomi
simpli
chemotaxonomi
plant
focus
classif
plant
base
chemic
composit
ie
secondari
metabolit
select
highlight
chemic
taxonomi
acetylen
compound
distribut
fatti
acid
plant
lipid
distribut
aliphat
polyol
cyclitol
plant
glycosid
alkaloid
chemotaxonomi
method
biolog
classif
base
similar
structur
certain
compound
produc
organ
question
eg
plant
protein
close
control
gene
less
subject
natur
select
anatom
featur
reliabl
indic
genet
relationship
phylogeni
approach
may
becom
signific
particular
compound
class
desir
known
biolog
activ
good
exampl
approach
target
datura
stramonium
tropan
alkaloid
knowledg
atropa
belladonna
contain
alkaloid
hyoscyamin
subsequ
lead
discoveri
similar
alkaloid
hyoscin
fig
heinrich
et
al
similarli
discoveri
alkaloid
febrifugin
fig
hydrangea
macrophylla
nativ
japanes
plant
result
target
plant
taxonom
statu
member
hydrangeacea
famili
heinrich
et
al
presenc
desir
chemic
may
reli
knowledg
toxic
particular
plant
rate
ecolog
plantpathogen
relationship
ottmann
et
al
plantpathogen
interact
molecular
framework
natur
product
play
signific
role
host
colon
pathogen
immun
molecul
outcom
coevolutionari
process
enrich
biolog
activ
investig
mode
action
natur
product
class
may
provid
signific
outcom
novel
molecul
discoveri
novel
concept
live
system
manipul
small
molecul
ottmann
et
al
ecolog
studybas
approach
scientist
select
plant
occupi
particular
habitat
display
characterist
indic
produc
molecul
possess
desir
properti
approach
base
ecolog
plant
defenc
theori
coley
et
al
instanc
absenc
predat
might
suggest
presenc
toxic
chemic
mani
phytochem
toxic
insect
also
exhibit
biolog
activ
human
might
exploit
therapeut
applic
observ
environ
reflect
toxicolog
properti
plant
led
isol
mani
antibacteri
drug
ecolog
approach
select
plant
materi
reli
observ
interact
organ
environ
might
lead
product
bioactiv
natur
compound
hypothesi
underpin
approach
secondari
metabolit
eg
plant
speci
possess
ecolog
function
may
also
therapeut
potenti
human
exampl
metabolit
involv
plant
defenc
microbi
pathogen
may
use
antimicrobi
human
secondari
product
defend
plant
herbivor
neurotox
activ
could
benefici
effect
human
due
put
central
nervou
system
activ
barbosa
et
al
major
potenti
limit
approach
lie
classif
medicin
plant
use
ernst
et
al
analys
medicin
plant
phylogenet
context
medicin
plant
document
collect
need
classifi
accord
diseas
use
treat
ethnomedicin
system
common
wide
use
classif
intern
classif
diseas
icd
classif
cook
develop
econom
botani
data
collect
standard
cook
classif
system
could
fulli
captur
complex
idiosyncrasi
local
healthcar
system
time
system
base
categori
reflect
system
human
bodi
symptom
system
provid
littl
inform
diseas
etiolog
potenti
underli
biolog
activ
medicin
plant
recent
year
extens
studi
cellular
molecular
mechan
underli
diseas
carri
provid
inform
diseas
etiolog
altern
approach
phylogenet
system
emerg
use
classif
base
modul
diseas
respons
ernst
et
al
taxonom
classif
current
default
classif
usual
angiosperm
phylogeni
group
iv
apg
iv
categor
assemblag
plant
speci
within
particular
categori
subcategori
need
base
phylogenet
relationship
apg
common
among
practic
taxonomist
theoret
variou
chemic
compound
use
reliabl
semantid
dna
rna
protein
provid
reliabl
taxonom
inform
howev
practic
applic
approach
far
perfect
mani
research
still
tri
compound
type
one
instanc
applic
graphclust
algorithm
metabolit
content
plant
led
success
classif
plant
japan
liu
et
al
approach
provid
success
result
even
incomplet
metabolit
data
obtain
consist
relationship
plant
cluster
known
evolut
relationship
plant
find
led
applic
predict
power
metabolit
content
explor
medicin
properti
plant
apart
establish
correl
plant
group
chemic
properti
develop
reliabl
cluster
analysi
visual
represent
dendrogram
remain
fundament
step
process
need
select
appropri
cluster
algorithm
applic
comput
tool
random
approach
popular
limit
result
requir
comput
mathemat
input
whatsoev
approach
plant
collect
regardless
previou
knowledg
phytochem
biolog
activ
approach
reli
avail
plant
pure
serendipiti
natur
heinrich
et
al
requir
lot
invest
term
money
time
sheer
amount
luck
approach
made
effect
contribut
develop
drug
mani
diseas
albuquerqu
et
al
two
approach
random
screen
first
approach
plant
screen
select
class
compound
like
alkaloid
flavonoid
coumarin
lignan
approach
usual
provid
idea
biolog
efficaci
second
approach
screen
randomli
select
plant
select
bioassay
focus
screen
well
gener
screen
central
drug
research
institut
india
start
approach
three
decad
back
though
institut
screen
plant
biolog
efficaci
screen
could
provid
new
drug
katiyar
et
al
unit
state
nation
cancer
institut
nation
institut
health
screen
plant
anticanc
activ
span
two
decad
result
discoveri
chemotyp
includ
taxan
camptothecin
fig
cragg
newman
develop
clinic
activ
agent
span
year
approach
also
call
knowledg
informationdriven
approach
take
consider
ethnobotan
random
chemotaxonom
approach
select
medicin
plant
katiyar
et
al
lin
et
al
comput
mathemat
tool
extens
appli
approach
relat
inform
particular
speci
integr
databas
priorit
screen
process
hypothesi
gener
subsequ
analysi
requir
care
assembl
overlay
comparison
data
diverg
sourc
import
databasedriven
inform
share
drug
discoveri
demonstr
largescal
product
taxol
fig
team
research
nation
cancer
institut
us
discov
extract
pacif
yew
taxu
brevifolia
contain
cytotox
activ
team
confirm
bioactiv
compon
extract
paclitaxel
also
known
trade
name
taxol
start
clinic
phase
number
cancer
type
taxol
approv
fda
treatment
ovarian
cancer
breast
cancer
howev
suppli
paclitaxel
major
challeng
compound
found
thin
bark
taxu
extrem
low
concentr
bark
singl
tree
could
provid
singl
dose
clinic
trial
lead
destruct
whole
plant
largescal
product
taxol
made
develop
sever
pathway
deriv
iii
noncytotox
precursor
taxol
precursor
initi
isol
franc
institut
de
chimi
de
substanc
naturel
gifsuryvett
needl
european
yew
taxu
baccata
french
scientist
one
kilogram
fresh
needl
provid
g
precursor
make
possibl
largescal
suppli
taxol
way
modern
drug
discoveri
approach
reli
variou
inform
resourc
curat
compil
variou
inform
differ
sourc
demand
access
share
differ
data
curat
servic
databas
statist
process
vari
inform
multivari
analysi
eg
princip
compon
analysi
discrimin
function
analysi
provid
potenti
understand
pattern
medicin
properti
sever
target
speci
detail
curat
medicin
plant
potenti
discuss
follow
section
phytochem
natur
product
gener
recogn
possess
characterist
high
chemic
divers
biochem
specif
properti
make
favour
lead
structur
drug
discoveri
programm
howev
assess
divers
chemic
space
effici
effect
still
impract
term
resourc
time
expect
applic
comput
approach
identif
bioactiv
phytochem
acceler
drug
discoveri
explor
chemic
space
cover
molecul
applic
natur
product
phytochem
librari
see
chapter
ligandbas
targetbas
virtual
screen
major
problem
usual
encount
silico
studi
biolog
activ
natur
product
includ
unavail
larg
natur
product
phytochem
databas
adequ
structur
biolog
inform
medicin
plant
databas
curat
inform
plant
cover
larg
spectrum
plant
properti
includ
formula
tradit
medicin
ningthoujam
et
al
dozen
databas
internet
resourc
avail
internet
provid
variou
type
inform
last
decad
develop
inclus
databas
inform
classif
activ
readi
dock
librari
medicin
plant
compound
essenti
drug
design
use
resourc
medicin
plant
mumtaz
et
al
one
particular
databas
could
provid
complet
pictur
medicin
plant
data
mine
share
differ
resourc
may
util
item
need
uniqu
identif
number
particular
plant
particular
entiti
databas
requir
provid
phytochem
pharmacolog
inform
medicin
plant
number
medicin
plant
databas
increas
year
year
special
comprehens
inform
give
opportun
studi
plant
util
tradit
knowledg
instanc
develop
global
natur
product
social
molecular
network
curat
inform
enabl
share
raw
process
identifi
tandem
mass
spectrometri
data
wang
et
al
anoth
exampl
curat
special
data
plant
protein
interact
data
intact
arabidopsi
inform
resourc
biogrid
etc
lee
et
al
data
curat
medicin
plant
databas
need
comprehens
far
possibl
serv
import
resourc
drug
discoveri
studi
aggreg
data
allow
research
visual
data
mine
analysi
produc
new
insight
aggreg
would
unachiev
data
dispers
within
larg
inaccess
format
rodriguez
et
al
challeng
encount
aggreg
data
aris
differ
format
mitig
ontolog
link
well
introduct
nosql
data
model
ningthoujam
et
al
rapidli
expand
inform
deriv
variou
analyt
exploratori
activ
role
medicin
plant
databas
also
progress
increas
hous
avail
inform
avail
comprehens
inform
particular
plant
speci
plant
group
would
acceler
analysi
predict
medicin
properti
variou
tool
techniqu
use
explor
medicin
properti
data
curat
medicin
plant
databas
well
analyt
method
qsar
molecular
model
virtual
screen
lagunin
et
al
softwar
tool
use
virtual
screen
identif
potenti
mechan
action
herbal
constitu
categor
barlow
et
al
shown
tabl
data
mine
process
sort
larg
dataset
identifi
pattern
establish
relationship
solv
problem
data
analysi
use
machinelearn
statist
method
afendi
et
al
yea
et
al
data
mine
method
use
variou
kind
inform
obtain
sourc
bibliograph
literatur
experiment
data
clinic
data
curat
data
vast
amount
data
store
databas
screen
identifi
potenti
natur
product
data
mine
approach
random
select
approach
consid
taxonom
affin
ethnomedicin
context
intrins
qualiti
howev
random
screen
associ
extrem
low
probabl
discoveri
use
compound
yea
et
al
consid
limit
random
select
advanc
method
propos
instanc
simpl
score
system
search
local
altern
phytolacca
dodecandra
develop
way
complex
despit
applic
simpl
score
regress
analysi
logic
formula
method
data
mine
random
select
success
mine
vast
bodi
inform
knowledg
pertain
biolog
medicin
botani
far
complet
still
today
mine
biomed
data
unearth
knowledg
gener
hypothesi
activ
research
field
one
major
innov
inclus
semant
inform
medic
subject
head
mesh
thesauru
cluster
document
medlin
databas
yea
et
al
approach
three
categori
contain
term
relat
herbal
compound
efficaci
toxic
metabol
process
select
subject
similar
measur
method
applic
novel
approach
data
mine
could
predict
herb
accur
similar
efficaci
compar
random
select
associ
rule
mine
one
power
tool
deriv
relationship
differ
factor
properti
chines
tradit
medicin
data
mine
aim
extract
structur
inform
discov
new
knowledg
larg
data
one
prerequisit
data
avail
lee
data
mine
techniqu
intric
relat
advanc
technolog
curat
medicin
plant
databas
medicin
plant
though
consid
lower
risk
complet
free
possibl
toxic
advers
effect
apart
inher
toxic
advers
effect
herbal
prepar
may
come
contamin
product
toxic
metal
adulter
misidentif
substitut
herbal
ingredi
improp
process
jordan
et
al
may
interact
drug
food
herbal
product
taken
concomitantli
consid
aspect
increas
concern
safeti
assess
herb
variou
protocol
guidanc
document
issu
document
issu
intern
life
scienc
institut
union
pure
appli
chemistri
european
medicin
agenc
european
food
safeti
author
discuss
assess
safeti
herb
use
food
medicin
assess
safeti
herbal
product
either
premarket
assess
postmarket
surveil
subject
challeng
data
defici
regard
quantiti
qualiti
inform
major
factor
effici
assess
proper
inform
advers
reaction
ideal
product
qualiti
composit
herbal
formula
toxic
constitu
requir
integr
paramet
reduc
uncertainti
decisionmak
fulfil
avail
inform
knowledg
base
develop
knowledg
base
requir
integr
variou
data
sourc
map
differ
inform
eg
toxic
bioassay
herbal
formula
contraind
aris
divers
domain
anoth
dimens
safeti
consider
applic
predict
toxicolog
computerassist
screen
assess
potenti
toxic
chemic
predict
toxicolog
contribut
aim
transform
toxicolog
test
primarili
observ
scienc
truli
predict
scienc
benefit
drug
develop
chemic
risk
assess
food
safeti
use
mathemat
comput
tool
predict
toxicolog
deal
develop
new
nonanim
test
simpli
duplic
exist
anim
test
offer
new
scientif
basi
safeti
test
reflect
signific
shift
away
advers
effect
observ
experiment
anim
sometim
high
dose
analys
effect
chronic
exposur
low
concentr
cell
organ
system
approach
offer
potenti
reliabl
reproduc
faster
costeffect
safeti
assess
new
product
develop
eg
new
drug
develop
eventu
regulatori
test
advantag
number
individu
chemic
screen
far
exceed
capac
assess
predict
toxicolog
properti
use
comput
toxicolog
method
qsar
assess
environment
chemic
variou
qsar
model
could
predict
ld
rat
mutagen
carcinogen
chemic
interest
increas
comput
predict
toxicolog
properti
silico
method
use
predict
cytotox
activ
sesquiterpen
lacton
member
asteracea
famili
fernand
et
al
use
artifici
neural
network
examin
compound
regard
cytotox
potenti
one
landmark
discoveri
made
valerio
use
qsar
model
rodent
carcinogen
di
sotto
et
al
report
genotox
assess
peperitenon
oxid
natur
flavour
agent
also
known
rotundifolon
fig
base
integr
vitro
silico
evalu
protocol
silico
part
studi
comput
predict
genotox
carri
use
toxtre
vega
tool
comput
predict
piperitenon
oxid
agre
toxicolog
data
highlight
presenc
epoxid
function
carbonyl
possibl
structur
alert
dna
damag
howev
felt
improv
toxicolog
librari
natur
occur
compound
essenti
augment
applic
silico
model
toxicolog
predict
studi
pleiotrop
pharmacolog
potenti
natur
product
deriv
medicin
plant
may
possibl
avail
medicin
plant
databas
store
inform
chemic
structur
therapeut
use
model
may
provid
answer
hitherto
unknown
problem
greatli
expand
knowledg
base
actual
studi
data
initi
scientif
commun
suffer
lack
larg
data
set
particularli
curat
biolog
activ
limit
overcom
extent
avail
mani
open
access
initi
like
pubchem
drugbank
chembank
chemspid
nevertheless
problem
still
persist
limit
manag
high
capac
data
sync
gener
big
data
abil
transform
data
meaning
knowledg
data
integr
diverg
sourc
differ
platform
coupl
increasingli
complex
multidisciplinari
approach
increas
need
data
analysi
interpret
